T. Kucharzik et al., SYNERGISTIC EFFECT OF IMMUNOREGULATORY CYTOKINES ON PERIPHERAL-BLOOD MONOCYTES FROM PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, Digestive diseases and sciences, 42(4), 1997, pp. 805-812
Active inflammatory bowel disease (IBD) is characterized by increased
monocyte secretion of proinflammatory cytokines. Immunoregulatory cyto
kines such as Interleukin (IL)-4, IL-10, and IL-13 are capable of inhi
biting the proinflammatory cytokine response of activated monocytes. T
he aim of our study was to determine the effect of different antiinfla
mmatory cytokines under various culture conditions and to evaluate com
binations of antiinflammatory cytokines in down-regulating monocyte re
sponse in IBD. Peripheral monocytes from patients with active IBD were
isolated and stimulated with pokeweed mitogen (PWM). IL-4, IL-10, IL-
13 and a combination of IL-4/IL-10 and IL-10/IL-13 were added at diffe
rent concentrations and different times. Secretion of IL-1 beta and TN
F-alpha was assessed using sandwich ELISA systems. There was a diminis
hed down-regulation of TNF-alpha by IL-4 and IL-13 in IBD when the cyt
okines were added at the time of stimulation, while there was a signif
icantly higher down-regulation when monocytes were primed with these T
h-2 cytokines 24 hr before activation. IL-10 plus IL-4 and IL-10 plus
IL-13, respectively, inhibited the proinflammatory cytokine response o
f monocytes as well as matured macrophages much more than IL-4, IL-10,
or IL-13 alone. Even at suboptimal concentrations for each cytokine a
lone, a combination of cytokines showed synergistic inhibitory effects
. In summary, a combination of antiinflammatory cytokines is more effe
ctive in down-regulating the response of activated monocytes than usin
g the cytokines alone and thus may have a potential therapeutic benefi
t for patients with IBD.